James Pursley Sells 16,000 Shares of Hinge Health (NYSE:HNGE) Stock

Hinge Health Inc. (NYSE:HNGE) President James Pursley sold 16,000 shares of the firm’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $53.79, for a total transaction of $860,640.00. Following the completion of the sale, the president directly owned 780,223 shares in the company, valued at approximately $41,968,195.17. This trade represents a 2.01% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Pursley also recently made the following trade(s):

• On Monday, March 23rd, James Pursley sold 15,000 shares of Hinge Health stock. The shares were sold at an average price of $42.26, for a total transaction of $633,900.00.

Hinge Health Trading Up 2.1%

Shares of HNGE opened at $54.72 on Friday. The firm’s 50-day moving average price is $45.82 and its 200-day moving average price is $44.59. The firm has a market capitalization of $4.23 billion and a price-to-earnings ratio of -4.43. Hinge Health Inc. has a 1-year low of $30.08 and a 1-year high of $62.18.

Hinge Health (NYSE:HNGE) last announced its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.33. The firm had revenue of $182.31 million for the quarter. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The company’s revenue for the quarter was up 47.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.30 EPS. On average, research analysts forecast that Hinge Health Inc. will post 1.21 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on HNGE. Royal Bank Of Canada lifted their target price on shares of Hinge Health from $55.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Zacks Research raised Hinge Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Needham & Company LLC boosted their target price on shares of Hinge Health from $59.00 to $63.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Stifel Nicolaus upped their target price on shares of Hinge Health from $59.00 to $67.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Finally, Barclays increased their price target on shares of Hinge Health from $52.00 to $62.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $67.40.

Institutional Investors Weigh In On Hinge Health

Several hedge funds have recently bought and sold shares of the business. California State Teachers Retirement System boosted its stake in Hinge Health by 35.2% during the first quarter. California State Teachers Retirement System now owns 19,141 shares of the company’s stock worth $738,000 after acquiring an additional 4,986 shares in the last quarter. Estuary Capital Management LP bought a new stake in Hinge Health during the first quarter worth about $15,201,000. Lazard Asset Management LLC boosted its stake in Hinge Health by 0.6% during the first quarter. Lazard Asset Management LLC now owns 63,705 shares of the company’s stock worth $2,456,000 after acquiring an additional 386 shares in the last quarter. Entropy Technologies LP boosted its stake in Hinge Health by 28.1% during the first quarter. Entropy Technologies LP now owns 11,749 shares of the company’s stock worth $453,000 after acquiring an additional 2,579 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its stake in Hinge Health by 225.7% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,163,187 shares of the company’s stock worth $44,852,000 after acquiring an additional 806,007 shares in the last quarter.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.